The effect of SGLT2 inhibitors on reducing the amount of epicardial adipose tissue and the beneficial impact of this phenomenon on fibrotic processes, improvement in myocardial contractility, prevention of arrhythmias, and HF seem to be very appealing [62,63]. This evidence concerns the gene SLC5A2 and hydrops fetalis.